March 18, 2023
1 min study
ADD Subject TO E-mail ALERTS
Obtain an e mail when new articles are posted on
Please deliver your e mail address to obtain an e mail when new articles are posted on .
” information-action=subscribe>
Subscribe
We had been unable to procedure your request. Please attempt once more later. If you continue to have this concern please make contact with customerservice@slackinc.com.
Back to Healio
Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), has been named enterprise vice president for cancer disparities at Jefferson Health’s Sidney Kimmel Cancer Center.
In this new function, Mitchell will be accountable for building and coordinating operations for cancer care disparities across Jefferson.
She will oversee a group focused on cancer care excellent and expense-effectiveness, as effectively as patient-oriented outcomes. She also will concentrate on identifying and eliminating barriers to care, especially these connected to socioeconomic, racial or ethnic disparities and social determinants of overall health.
Edith P. Mitchell
“Dr. Mitchell has had an extraordinary profession devoted to eliminating overall health disparities affecting as well a lot of folks and communities in the Philadelphia region and beyond,” Andrew Chapman, DO, director of Sidney Kimmel Cancer Center and executive vice president of oncology solutions at Jefferson Overall health, mentioned in a press release. “Her operate with neighborhood overall health providers has improved minority participation in clinical trials and she has brought cancer screening to neighborhoods lacking access to preventive care. Dr. Mitchell’s experience and devotion to overall health equity is invaluable to the Sidney Kimmel Cancer Center in our commitment to provide higher-excellent cancer care across the area.”
Mitchell also serves as director of Center to Do away with Cancer Disparities and clinical professor of medicine and healthcare oncology at Jefferson Health’s Sidney Kimmel Cancer Center. She joined Jefferson in 1995.
Her investigation has focused on barriers to clinical trial participation, as effectively as novel drug evaluation and new remedy regimens for individuals with breast cancer or gastrointestinal cancers.
ADD Subject TO E-mail ALERTS
Obtain an e mail when new articles are posted on
Please deliver your e mail address to obtain an e mail when new articles are posted on .
” information-action=subscribe>
Subscribe
We had been unable to procedure your request. Please attempt once more later. If you continue to have this concern please make contact with customerservice@slackinc.com.
Back to Healio
Weiterleitungshinweis